SBIR/STTR Research Award

Exonuclease Epigenetic Sequencing

Award identifier 9dfd8a43dd0ae9a203bce96c2047e3e517f5a185314b455cfe5e967e3bddc7ccAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$276,492

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ELECTRONIC BIOSCIENCES, INC.
Proposal award date
2018-09-01
Contract end date
2019-08-31
UEI
FLHHE89XH2H5
Solicitation number
HG15-033
Topic code
172

Research abstract

Project Summary There is a current need within the field of next generation sequencingNGSfor newenabling instrumentationcapable of high accuracydirectnative DNA sequencingincluding the identification of canonical and modified bases and the correct characterization of homopolymer stretches and repeating sequencesDuring this programElectronic BioSciencesEBSand a team of field experts aim to solve the technical challenges associated with the development of a completely new and novel nanopore based sequencing platformincluding the associated methodology for sequencing DNA at the single nucleotide levelwith the capability of directly and correctly identifying chemically modified nucleotidesDuring this projectefforts will specifically focus on the high accuracy detection identification ofmethylcytosinemCand Nmethyladeninem Asequencingbefore pursuing other modificationsAt presentthe scientific community s understanding of theepigenomei ethe chemical modifications which regulate the function of DNAis still in its infancyWhile there are many known chemical modifications to either the base or sugar phosphate backbone of nucleic acidsdue to the lack of analytical characterization methods availablethe exact roles of these modifications remain to be assessedNew technologies capable of elucidating the roles of these modifications have the potential to revolutionize the use of the epigenomeFurthermorewith regards to homopolymer and repeat sequences of andgtnucleotides which are commonly found in genomesclinicians have identified that many of these sequences are expandedcontractedor mutated in cancersneurological disordersand heritable diseasesand thereforesequencing for changes in these regions has promising potential for utilization as routine genetic markers for diagnostics and prognostics purposesAt the conclusion of this Fast Track projecta multiplexed sequencing instrument that is ready for immediateexpandedinitial user base use in laboratory settings will be developed and builtand complete concept feasibility will have been demonstrated through both synthetic and genomic DNA sequencingincludingmC and m A characterization Project Narrative The direct sequencing of chemical modifications in the genome with high accuracy would facilitate an explosion of epigenetic sequencing data that has otherwise not been attainable to dateThusthe methodology technology that will be developed during this project has the potential to revolutionize the use and understanding of the genome and epigenomeMore long termthese results would better enable the use of epigenetic markers in clinical diagnostics and prognosticsprovide a deeper understanding of infectious diseasesallow cultivation of better cropsand advance our basic understanding of all domains of biologyin addition to empowering unforeseen fieldssuch as epigenomic diagnostics and therapeutics

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

58 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $22,847,588. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Environmental Protection Agency, Department of Defense, Department of Commerce

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.